135 related articles for article (PubMed ID: 6360431)
1. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man.
Barbieri C; Magnoni V; Rauhe WG; Zanasi S; Caldara R; Ferrari C
Clin Endocrinol (Oxf); 1983 Dec; 19(6):705-10. PubMed ID: 6360431
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
Altomonte L; Zoli A; Alessi F; Ghirlanda G; Manna R; Greco AV
Horm Res; 1987; 27(4):190-4. PubMed ID: 3436616
[TBL] [Abstract][Full Text] [Related]
3. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
[TBL] [Abstract][Full Text] [Related]
4. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.
Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Sgrò M; Franchi F; Luisi M
Horm Res; 1989; 31(3):133-7. PubMed ID: 2501208
[TBL] [Abstract][Full Text] [Related]
5. Naloxone reduces the fenfluramine-induced prolactin release in man.
Foresta C; Scanelli G; Indino M; Federspil G; Scandellari C
Clin Endocrinol (Oxf); 1985 Apr; 22(4):539-43. PubMed ID: 3987071
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic regulation of prolactin and growth hormone secretion in man.
Lewis DA; Sherman BM
Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
[TBL] [Abstract][Full Text] [Related]
7. Naloxone does not modify fenfluramine-induced prolactin increase in obese patients.
Argenio GF; Bernini GP; Vivaldi MS; del Corso C; Santoni R; Franchi F
Clin Endocrinol (Oxf); 1991 Dec; 35(6):505-8. PubMed ID: 1769132
[TBL] [Abstract][Full Text] [Related]
8. Central serotoninergic stimulation by fenfluramine challenge does not affect plasma thyrotropin-stimulating hormone levels in man.
Coccaro EF; Siever LJ; Kourides IA; Adan F; Campbell G; Davis KL
Neuroendocrinology; 1988 Apr; 47(4):273-6. PubMed ID: 3374753
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenfluramine on prolactin and thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in obese and normal women.
Argenio G; Bernini G; Vivaldi MS; Del Corso C; Monzani F; Baschieri L; Bertolozzi G; Santoni R; Franchi F; Luisi M
Eur J Clin Pharmacol; 1990; 39(1):13-6. PubMed ID: 2125937
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.
Barbieri C; Parodi M; Bruno S; Bertassi F; Benaglia D; Moser P; Meroni R; Dubini A
Eur J Clin Pharmacol; 1984; 26(1):29-32. PubMed ID: 6143669
[TBL] [Abstract][Full Text] [Related]
11. Role of gonadal steroids in the serotoninergic control of prolactin secretion in men.
Foresta C; Indino M; Scandellari C
Clin Endocrinol (Oxf); 1987 May; 26(5):601-7. PubMed ID: 3665121
[TBL] [Abstract][Full Text] [Related]
12. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients.
Weizman A; Mark M; Gil-Ad I; Tyano S; Laron Z
Clin Neuropharmacol; 1988 Jun; 11(3):250-6. PubMed ID: 2969772
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
Van de Kar LD; Urban JH; Richardson KD; Bethea CL
Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613
[TBL] [Abstract][Full Text] [Related]
14. Evidence for serotoninergic system involvement in opioid control of luteinizing hormone secretion in man.
Foresta C; Mioni R; Scandellari C
Clin Endocrinol (Oxf); 1986 Nov; 25(5):573-8. PubMed ID: 3621624
[TBL] [Abstract][Full Text] [Related]
15. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.
Quattrone A; Tedeschi G; Aguglia U; Scopacasa F; Direnzo GF; Annunziato L
Br J Clin Pharmacol; 1983 Nov; 16(5):471-5. PubMed ID: 6639832
[TBL] [Abstract][Full Text] [Related]
16. Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man.
Palazidou E; Stephenson J; Butler J; Coskeran P; Chambers S; McGregor AM
Psychopharmacology (Berl); 1995 Jun; 119(3):311-4. PubMed ID: 7675967
[TBL] [Abstract][Full Text] [Related]
17. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
[TBL] [Abstract][Full Text] [Related]
18. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.
Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H
J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
[TBL] [Abstract][Full Text] [Related]
20. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
Maes M; Jacobs MP; Suy E; Minner B; Raus J
Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
